Literature DB >> 11053045

Functional expression of novel peptide transporter in renal basolateral membranes.

T Terada1, K Sawada, T Ito, H Saito, Y Hashimoto, K Inui.   

Abstract

We examined the peptide transport activity in renal basolateral membranes. [(14)C]glycylsarcosine (Gly-Sar) uptake in rat renal cortical slices was saturable and inhibited by excess dipeptide and aminocephalosporin cefadroxil. When several renal cell lines were screened for the basolateral peptide transport activity, Madin-Darby canine kidney (MDCK) cells were demonstrated to have the greatest transport activity. [(14)C]Gly-Sar uptake across the basolateral membranes of MDCK cells was inhibited by di- and tripeptide and decreased with decreases in extracellular pH from 7.4 to 5.0. The Michaelis-Menten constant value of [(14)C]Gly-Sar uptake across the basolateral membranes of MDCK cells was 71 microM. The basolateral peptide transporter in MDCK cells showed several different [(14)C]Gly-Sar transport characteristics in growth dependence, pH profile, substrate affinity, and sensitivities to chemical modifiers from those of the apical H(+)-peptide cotransporter of MDCK cells. The findings of the present investigation indicated that the peptide transporter was expressed in the renal basolateral membranes. In addition, from the functional characteristics, the renal basolateral peptide transporter was suggested to be distinguishable from known peptide transporters, i.e., H(+)-peptide cotransporters (PEPT1 and PEPT2) and the intestinal basolateral peptide transporter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053045     DOI: 10.1152/ajprenal.2000.279.5.F851

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

2.  Functional Expression of PEPT2 in the Human Distal Lung Epithelial Cell Line NCl-H441.

Authors:  Mikihisa Takano; Natsumi Sugimoto; Carsten Ehrhardt; Ryoko Yumoto
Journal:  Pharm Res       Date:  2015-07-14       Impact factor: 4.200

3.  Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.

Authors:  Sheetal Agarwal; Ritesh Jain; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2006-10-10       Impact factor: 5.875

4.  Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: interactions with peptide transporters.

Authors:  Wendy S Putnam; Lin Pan; Ken Tsutsui; Lori Takahashi; Leslie Z Benet
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

5.  Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.

Authors:  Dilara Jappar; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

6.  Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.

Authors:  Zhiying Wang; Dhananjay Pal; Ashaben Patel; Deep Kwatra; Ashim K Mitra
Journal:  Int J Pharm       Date:  2012-12-20       Impact factor: 5.875

7.  Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy.

Authors:  Yanxia Gong; Jie Zhang; Xiang Wu; Tao Wang; Jia Zhao; Zhi Yao; Qingyu Zhang; Xi Liu; Xu Jian
Journal:  Oncol Lett       Date:  2017-08-04       Impact factor: 2.967

8.  Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation Conditions.

Authors:  Yong Quan; Yisheng Jin; Teresa N Faria; Charles A Tilford; Aiqing He; Doris A Wall; Ronald L Smith; Balvinder S Vig
Journal:  Pharmaceutics       Date:  2012-06-18       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.